Home › Funds › Vestal Point Capital, LP › TVTX

Vestal Point Capital, LP position in TVTX

TRAVERE THERAPEUTICS INC · Health Care

Vestal Point Capital, LP reported holding 600,000 shares of TVTX (TRAVERE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$35.3M, representing 0.91% of its reported portfolio and ranking #20 among its reported holdings. Vestal Point Capital, LP has disclosed TVTX holdings in 2 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)600.00K sh
Reported value held$35.33M
Portfolio Weight0.91%
First reportedQ2 2025
Last changeNew
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Vestal Point Capital, LP's TVTX position evolved

Vestal Point Capital, LP first disclosed a stake in TVTX in Q2 2025 at 355,000 shares (US$5.3M). The position peaked in Q3 2026 at 600,000 shares, worth US$35.3M. Across 2 filings, Vestal Point Capital, LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 600,000 shares valued at US$35.3M.

Quarter by quarter

QuarterSharesValueChange
Q2 2025 355.00K $5.25M New
Q3 2026 600.00K $35.33M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TVTX and 13F data

TVTX (TRAVERE THERAPEUTICS INC) is a Health Care company. 56 other funds we track also report a position in TVTX — the largest reported positions include PERCEPTIVE ADVISORS LLC (US$208.6M), Rock Springs Capital Management LP (US$129.8M), Kynam Capital Management, LP (US$117.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TVTX

All TVTX fund holders →

FAQ

How long has Vestal Point Capital, LP held TVTX?

Vestal Point Capital, LP has disclosed TVTX holdings in 2 of the last 6 reported quarters, going back to Q2 2025.

What is Vestal Point Capital, LP's current position in TVTX?

As of Q3 2026, Vestal Point Capital, LP holds 600.00K shares of TVTX (TRAVERE THERAPEUTICS INC), valued at $35.33M, representing 0.91% of its reported portfolio and ranking #20.

Has Vestal Point Capital, LP been buying or selling TVTX?

In the latest 13F filing (Q3 2026), Vestal Point Capital, LP newly opened its position in TVTX. The position peaked in Q3 2026 at 600.00K shares.

Which other funds hold TVTX?

Other major institutional holders of TVTX include PERCEPTIVE ADVISORS LLC, Rock Springs Capital Management LP, Kynam Capital Management, LP, among 56 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.